Palonosetron Related Compound A is a structurally analogous impurity derived from the parent drug, characterized by a substituted piperazine ring connected to a pyridine core. The absence of a fluorine atom at the 2-position of the indole moiety, replaced by a methylene group, distinguishes it from Palonosetron. This compound features a 4-(4-methylpiperazin-1-yl)phenol substructure linked via an ethyl bridge to the pyridine ring. It serves as a critical HPLC reference standard for quantifying process-related impurities in Palonosetron API synthesis.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1492222 โ | 15 mg | USD 939.00 |
C1C[C@@H]2CN(C(=O)C3=CC=CC(=C23)C1)[C@@H]4C[N+]5(CCC4CC5)[O-]
InChI=1S/C19H24N2O2/c22-19-16-6-2-4-14-3-1-5-15(18(14)16)11-20(19)17-12-21(23)9-7-13(17)8-10-21/h2,4,6,13,15,17H,1,3,5,7-12H2/t13?,15-,17-,21?/m1/s1
IQQIWUDYGYXXEA-BGAFOXLKSA-N